2023-10-01 2024-09-30 false No description of principal activity Capium Accounts Production 1.1 12230466 2023-10-01 2024-09-30 12230466 bus:FullAccounts 2023-10-01 2024-09-30 12230466 bus:FRS102 2023-10-01 2024-09-30 12230466 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12230466 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12230466 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12230466 2023-10-01 2024-09-30 12230466 2024-09-30 12230466 bus:RegisteredOffice 2023-10-01 2024-09-30 12230466 core:WithinOneYear 2024-09-30 12230466 core:AfterOneYear 2024-09-30 12230466 1 2023-10-01 2024-09-30 12230466 bus:Director1 2023-10-01 2024-09-30 12230466 bus:Director1 2024-09-30 12230466 bus:Director1 2022-10-01 2023-09-30 12230466 2022-10-01 12230466 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 12230466 2022-10-01 2023-09-30 12230466 2023-09-30 12230466 core:WithinOneYear 2023-09-30 12230466 core:AfterOneYear 2023-09-30 12230466 bus:EntityAccountantsOrAuditors 2022-10-01 2023-09-30 12230466 core:MotorCars 2023-10-01 2024-09-30 12230466 core:MotorCars 2024-09-30 12230466 core:MotorCars 2023-09-30 12230466 core:FurnitureFittings 2023-10-01 2024-09-30 12230466 core:FurnitureFittings 2024-09-30 12230466 core:FurnitureFittings 2023-09-30 12230466 core:ComputerEquipment 2023-10-01 2024-09-30 12230466 core:ComputerEquipment 2024-09-30 12230466 core:ComputerEquipment 2023-09-30 12230466 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 12230466 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 12230466 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 12230466 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 12230466 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 12230466 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 12230466 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 12230466 core:Non-currentFinancialInstruments 2024-09-30 12230466 core:Non-currentFinancialInstruments 2023-09-30 12230466 core:ShareCapital 2024-09-30 12230466 core:ShareCapital 2023-09-30 12230466 core:RetainedEarningsAccumulatedLosses 2024-09-30 12230466 core:RetainedEarningsAccumulatedLosses 2023-09-30 12230466 dpl:Item1 2023-10-01 12230466 dpl:Item1 2024-09-30 12230466 dpl:Item1 2022-10-01 12230466 dpl:Item1 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12230466
England and Wales

 

 

 

7K HEALTHCARE LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 October 2023

End date: 30 September 2024
Director Swapnkumar Mukeshbhai Patel
Registered Number 12230466
Registered Office 231 Kenton Road
Harrow
England
HA3 0HD
Accountants 3E'S Accountants Limited
231 Kenton Road
Harrow
Middlesex
England
HA3 0HD
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 6,577    6,398 
6,577    6,398 
Current assets      
Debtors 4 609,636    591,289 
Cash at bank and in hand 70,273    85,051 
679,909    676,340 
Creditors: amount falling due within one year 5 (320,008)   (370,372)
Net current assets 359,901    305,968 
 
Total assets less current liabilities 366,478    312,366 
Creditors: amount falling due after more than one year 6 (12,250)   (19,251)
Net assets 354,228    293,115 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 354,128    293,015 
Shareholders' funds 354,228    293,115 
 


For the year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 10 June 2025 and were signed by:


-------------------------------
Swapnkumar Mukeshbhai Patel
Director
2
General Information
7K Healthcare Ltd is a private company, limited by shares, registered in England and Wales, registration number 12230466, registration address 231 Kenton Road, Harrow, England, HA3 0HD.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividend Income
During the year, 7k Healthcare Ltd received £95,000 in dividends from SNS Absolute Care Limited. This income is accounted for under 'Other Income' in the income statement, reflecting the return on the investment.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25% Reducing Balance
Fixtures and fittings 33.33% Straight Line
Computer Equipment 33.33% Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Fixtures and fittings   Computer Equipment   Total
  £   £   £   £
At 01 October 2023 19,344    2,366    2,782    24,492 
Additions     2,491    2,491 
Disposals      
Transfers   (789)     (789)
At 30 September 2024 19,344    1,577    5,273    26,194 
Depreciation
At 01 October 2023 13,223    1,577    2,505    17,305 
Charge for year 1,531      781    2,312 
On disposals      
At 30 September 2024 14,754    1,577    3,286    19,617 
Net book values
Closing balance as at 30 September 2024 4,590      1,987    6,577 
Opening balance as at 01 October 2023 6,121      277    6,398 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Trade Debtors   270,000 
Other Debtors 409,636    321,289 
409,636    591,289 

4.

Debtors: amounts falling due after one year

2024
£
  2023
£
Other Debtors 200,000   
200,000   

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors 265,800    95,750 
Taxation and Social Security 36,487    127,213 
Other Creditors 17,721    147,409 
320,008    370,372 

6.

Creditors: amount falling due after more than one year

2024
£
  2023
£
Other Creditors 12,250    19,251 
12,250    19,251 

3